financetom
Business
financetom
/
Business
/
Govt approves Rs 25,215 crore RIL-Brookfield mobile tower deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Govt approves Rs 25,215 crore RIL-Brookfield mobile tower deal
Sep 1, 2020 4:04 AM

The government has approved the Rs 25,215-crore deal between a subsidiary of Reliance Industries and Canadian firm Brookfield Infrastructure Partners LP, involving sale of over 1.35 lakh mobile towers, according to a regulatory filing.

Reliance Industries' unit, Reliance Industrial Investments and Holdings Ltd (RIIHL), renamed as RPPMSL, had inked binding agreements with Brookfield Infrastructure Partners LP and its partners for the tower business deal in December 2019.

"The Brookfield Sponsor has entered into the Deed of Accession dated August 26, 2020, with the Reliance Sponsor and the Trustee, upon receipt of the approval from Department of Telecommunications (DoT) dated August 11, 2020," a regulatory filing by Brookfield's Tower Infrastructure Trust dated August 28 said.

The Tower Company, Reliance Jio Infocomm Limited and Reliance Projects & Property Management Services Limited (RPPMSL) have entered into a master service agreement to execute the deal under which Reliance Jio will remain the tenant of the new entity for the next 30 years. The asset base of Tower Company as on March 31, 2020 was 1,35,047 towers which it plans to scale up to 1,74,451 during the current financial year.

Also Read

: SC rules 10-year timeline for staggered payment of AGR dues effective April 1, 2021: Here are the main highlights

Currently, Reliance Jio Infocomm Limited is the sole tenant of the Tower Sites.

"The Tower Co holds completed and revenue generating assets with some more towers planned for construction in future and therefore the investment is in compliance with the InvIT Regulations," the filing said.

Brookfield has purchased 100 percent equity of the operating tower company.

Proceeds from the investment by Brookfield and long-term loans will be used to repay existing financial liabilities of Reliance Jio Infratel Pvt Ltd (RJIPL), including loans extended by RIL.

First Published:Sept 1, 2020 1:04 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Tesla's China-Made EV Sales Drop 11.5% in March
Market Chatter: Tesla's China-Made EV Sales Drop 11.5% in March
Apr 2, 2025
07:45 AM EDT, 04/02/2025 (MT Newswires) -- Tesla (TSLA) sold 78,828 China-made electric vehicles in March, down 11.5% from a year ago, Reuters reported Wednesday, citing data from the China Passenger Car Association. However, deliveries of the China-made Model 3 and Model Y cars during the month increased 156.9% from February, the report said. The company delivered 172,754 China-made cars...
CI Global Asset Management Announced JFT Strategies Fund Renewing At-The-Market Equity Program
CI Global Asset Management Announced JFT Strategies Fund Renewing At-The-Market Equity Program
Apr 2, 2025
07:50 AM EDT, 04/02/2025 (MT Newswires) -- CI Global Asset Management announced Wednesday that JFT Strategies Fund (JFS-UN.TO) has renewed its at-the-market equity program. A statement noted the ATM Program allows the Fund to issue Class A units having an aggregate sale price of up to $100 million to the public from time to time, at the discretion of CI...
Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program
Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program
Apr 2, 2025
07:46 AM EDT, 04/02/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said Wednesday that Sanofi ( SNY ) has exclusively licensed an undisclosed Nurix program targeting a previously undruggable transcription factor for autoimmune diseases. The company said the target is a key regulator of inflammation and is separate from its earlier disclosed STAT6 degrader program. Under the collaboration, Nurix...
BlackBerry Reports Higher Q4 Adjusted Net Income That Beats Forecasts
BlackBerry Reports Higher Q4 Adjusted Net Income That Beats Forecasts
Apr 2, 2025
07:48 AM EDT, 04/02/2025 (MT Newswires) -- BlackBerry (BB.TO) on Wednesday reported higher fourth-quarter adjusted profit that beat forecasts. The adjusted net income for the three months ending February 28, climbed to US$17.7 million, or US$0.03 per share, from US$16.4 million, or US$0.03 per share in the prior year period. The result beat analysts' expectations of US$ nil per share,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved